Sitagliptin Phosphate [sitagliptin fosfát]
topical
72
- Terms
-
fosfát sitagliptinu
Januvia
sitagliptin
Tesavel
-
4-Oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine
Januvia
MK 0431
MK-0431
MK0431
Sitagliptin
Sitagliptin Monophosphate Monohydrate
Sitagliptin Phosphate Anhydrous
Sitagliptin Phosphate Monohydrate
Persistent link
https://www.medvik.cz/link/D000068900
Definition
A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES.
- DUI
- D000068900 MeSH Browser
- CUI
- M0498840
- History note
- 2016 (2005)
- Public note
- 2016; SITAGLIPTIN PHOSPHATE was indexed under PYRAZINES and TRIAZOLES 2005-2015
Allowable subheadings
- AD
- administration & dosage 29
- AE
- adverse effects 27
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification
- EC
- economics
- HI
- history 3
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 2
- PD
- pharmacology 12
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 47
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records